Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |